The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Open accessAbstract
The definition and assessment of adherence vary considerably across studies. Increasing consensus regarding these issues is necessary to improve our understanding of adherence and the development of more effective treatments. We review the adherence literature over the past 3 decades to explore the definitions and assessment of adherence to oral antipsychotics in schizophrenia patients. A total of 161 articles were identified through MEDLINE and PsycINFO searches. The most common method used to assess adherence was the report of the patient. Subjective and indirect methods including self-report, provider report, significant other report, and chart review were the only methods used to assess adherence in over 77% (124/161) of studies reviewed. Direct or objective measures including pill count, blood or urine analysis, electronic monitoring, and electronic refill records were used in less than 23% (37/161) of studies. Even in studies utilizing the same methodology to assess adherence, definitions of an adherent subject varied broadly from agreeing to take any medication to taking at least 90% of medication as prescribed. We make suggestions for consensus development, including the use of recommended terminology for different subject samples, the increased use of objective or direct measures, and the inclusion in all studies of an estimate of the percentage of medication taken as prescribed in an effort to increase comparability among studies. The suggestions are designed to advance the field with respect to both understanding predictors of adherence and developing interventions to improve adherence to oral antipsychotic medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
The American Journal of Managed Care
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc · Cited by 3,237
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 2,143
(1986) · Reliability and Validity in Qualitative Research · doi:10.4135/9781412985659.n2 · Cited by 1,375
Assessment of insight in psychosis
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.873 · Cited by 1,095
Hogan, T. P., Awad, A. G., & Eastwood, R. (1983) · Psychological Medicine · doi:10.1017/s0033291700050182 · Cited by 1,028
Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses
Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00130-9 · Cited by 981
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.637 · Cited by 957
Compliance therapy in psychotic patients: randomised controlled trial
Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996) · BMJ · doi:10.1136/bmj.312.7027.345 · Cited by 633
Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.886 · Cited by 621
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603 · cited 1×
“…et al. (2001)63 Prospective naturalistic study comparing medications 2657 Provider report High = 80%, moderate = 60–79%, low = 20–59%, nil = <20% Gilmer et al. (2004)64 Adherence to antipsychotics and health care costs* 2801 Electronic refill (Medi-Cal Database) Cumulative possession…”
BackgroundFalloon, I. R. H. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320059008 · Cited by 586
Multiple-Family Groups and Psychoeducation in the Treatment of Schizophrenia
McFarlane, W. R. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950200069016 · Cited by 560
Frank, A. F. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150028006 · Cited by 552 · cited 1×
“…scale, DAI continuous Frangou et al. (2005)57 Telemonitoring of adherence* 108 MEMS and Internet monitor % taken/prescribed over entire study period Frank and Gunderson (1990)58 Therapeutic alliance 143 Self-report, provider report, chart review Noncompliant = unilaterally altered dose, did…”
BackgroundInterventions to Improve Medication Adherence in Schizophrenia
Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1653 · Cited by 542
Insight in Schizophrenia. Its Relationship to Acute Psychopathology
McEVOY, J. P., APPERSON, L. J., APPELBAUM, P. S., ORTLIP, P., BRECOSKY, J., HAMMILL, K., GELLER, J. L., & ROTH, L. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198901000-00007 · Cited by 529
Randomised controlled trial of compliance therapy: 18-month follow-up
Kemp, R., Kirov, G., Everitt, B., Hayward, P., & David, A. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.5.413 · Cited by 520
Obesity as a risk factor for antipsychotic noncompliance
Weiden, P. J., Mackell, J. A., & McDonnell, D. D. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00498-x · Cited by 433
Substance Abuse Among the Chronic Mentally Ill
Drake, R. E., & Wallach, M. A. (1989) · Psychiatric Services · doi:10.1176/ps.40.10.1041 · Cited by 417
Medication adherence of individuals with a first episode of psychosis
Coldham, E. L., Addington, J., & Addington, D. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02437.x · Cited by 413
Predicting Medication Noncompliance After Hospital Discharge Among Patients With Schizophrenia
Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. J. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.2.216 · Cited by 410
Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?
Dolder, C. R., Lacro, J. P., Dunn, L. B., & Jeste, D. V. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.103 · Cited by 386
Day, J. C., Bentall, R. P., Roberts, C., Randall, F., Rogers, A., Cattell, D., Healy, D., Rae, P., & Power, C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.717 · Cited by 360
Family-Based Intervention for Schizophrenic Patients in China: A Randomised Controlled Trial
Xiong, W., Phillips, M. R., Hu, X., Wang, R., Dai, Q., Kleinman, J., & Kleinman, A. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.165.2.239 · Cited by 341
Medication noncompliance and substance abuse among patients with schizophrenia
(1996) · Psychiatric Services · doi:10.1176/ps.47.8.853 · Cited by 330
Robinson, D. G., Woerner, M. G., Alvir, J. M. J., Bilder, R. M., Hinrichsen, G. A., & Lieberman, J. A. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00312-7 · Cited by 290
Svarstad, B. L., Shireman, T. I., & Sweeney, J. K. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.6.805 · Cited by 281
Rating of Medication Influences (ROMI) Scale in Schizophrenia
Weiden, P., Rapkin, B., Mott, T., Zygmunt, A., Goldman, D., Horvitz-Lennon, M., & Frances, A. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.2.297 · Cited by 274
Drug Refusal in Schizophrenia and the Wish to Be Crazy
Van Putten, T. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770120047004 · Cited by 260
A community ability scale for chronically mentally Ill consumers: Part I. Reliability and validity
Barker, S., Barron, N., McFarland, B. H., & Bigelow, D. A. (1994) · Community Mental Health Journal · doi:10.1007/bf02207489 · Cited by 250
Subjective Response to Antipsychotic Drugs
Van Putten, T. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780270073010 · Cited by 223
Compliance therapy: a randomised controlled trial in schizophrenia
O'Donnell, C., Donohoe, G., Sharkey, L., Owens, N., Migone, M., Harries, R., Kinsella, A., Larkin, C., & O'Callaghan, E. (2003) · BMJ · doi:10.1136/bmj.327.7419.834 · Cited by 219
Pill Count, Self-Report, and Pharmacy Claims Data to Measure Medication Adherence in the Elderly
Grymonpre, R. E., Didur, C. D., Montgomery, P. R., & Sitar, D. S. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17423 · Cited by 214
Hunt, G. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00261-4 · Cited by 208
Predicting medication adherence in severe mental disorders
Adams, J., & Scott, J. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.90061.x · Cited by 208
Non-adherence to antipsychotic medication regimens: Associations with resource use and costs
Knapp, M., King, D., Pugner, K., & Lapuerta, P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.509 · Cited by 191
Jeste, S. D., Patterson, T. L., Palmer, B. W., Dolder, C. R., Goldman, S., & Jeste, D. V. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00314-6 · Cited by 184
Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F., Carmody, T., Magouirk, B., & Rush, A. J. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.11.002 · Cited by 181
Deviation from prescribed drug treatment after discharge from hospital.
Parkin, D. M., Henney, C. R., Quirk, J., & Crooks, J. (1976) · BMJ · doi:10.1136/bmj.2.6037.686 · Cited by 180
Effect of Patient Education on Medication Compliance
Seltzer, A., Roncari, I., & Garfinkel, P. (1980) · The Canadian Journal of Psychiatry · doi:10.1177/070674378002500807 · Cited by 173
Awareness of Illness in Schizophrenia and Outpatient Treatment Adherence
CUFFEL, B. J., ALFORD, J., FISCHER, E. P., & OWEN, R. R. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199611000-00001 · Cited by 169
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1749 · Cited by 160
Hodgins, S., Tiihonen, J., & Ross, D. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.021 · Cited by 160
Indicators of medication compliance in first-episode psychosis
Kampman, O., Laippala, P., Väänänen, J., Koivisto, E., Kiviniemi, P., Kilkku, N., & Lehtinen, K. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00030-6 · Cited by 158
Swanson, J. W., Swartz, M. S., & Elbogen, E. B. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007065 · Cited by 156
A Controlled Study of Education About Drug Treatment in Schizophrenia
Macpherson, R., Jerrom, B., & Hughes, A. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.6.709 · Cited by 156
Compliance with antipsychotic treatment
Oehl, M., Hummer, M., & Fleischhacker, W. W. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.00016.x · Cited by 151
Aichhorn, W., Whitworth, A. B., Weiss, E. M., & Marksteiner, J. (2006) · Drug Safety · doi:10.2165/00002018-200629070-00004 · Cited by 150
Verghese, A., John, J., Rajkumar, S., Richard, J., Sethi, B. B., & Trivedi, J. K. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.4.499 · Cited by 150
Neurological Soft Signs in First-Episode Schizophrenia: A Follow-Up Study
Bachmann, S., Bottmer, C., & Schröder, J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2337 · Cited by 147
Utility of the health belief model in examining medication compliance among psychiatric outpatients
Kelly, G. R., Mamon, J. A., & Scott, J. E. (1987) · Social Science & Medicine · doi:10.1016/0277-9536(87)90367-4 · Cited by 144
Merinder, L. B., Viuff, A. G., Laugesen, H., Clemmensen, K., Misfelt, S., & Espensen, B. (1999) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050146 · Cited by 142
Freudenreich, O., Cather, C., Evins, A. E., Henderson, D. C., & GOFF, D. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1012 · Cited by 141
Medication Compliance and Health Education Among Outpatients With Chronic Mental Disorders
Kelly, G. R., Scott, J. E., & Mamon, J. (1990) · Medical Care · doi:10.1097/00005650-199012000-00006 · Cited by 139
Teaching Medication Management Skills to Schizophrenic Patients
Eckman, T. A., Liberman, R. P., Phipps, C. C., & Blair, K. E. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199002000-00006 · Cited by 136
Adherence to Conventional and Atypical Antipsychotics After Hospital Discharge
Díaz, E., Neuse, E. C., Sullivan, M. C., Pearsall, R., & Woods, S. W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0311 · Cited by 136
Predictors of Risk of Nonadherence in Outpatients With Schizophrenia and Other Psychotic Disorders
Weiss, K. A., Smith, T. E., Hull, J. W., Piper, A. C., & Huppert, J. D. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006943 · Cited by 136
Löffler, W., Kilian, R., Toumi, M., & Angermeyer, M. C. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-39985 · Cited by 135
Frequent Rehospitalization and Noncompliance With Treatment
Green, J. H. (1988) · Psychiatric Services · doi:10.1176/ps.39.9.963 · Cited by 134
Insight and adherence to medication in chronic schizophrenics.
Lin, I. F., Spiga, R., & Fortsch, W. (1979) · PubMed · Cited by 134
Bechdolf, A., Knost, B., Kuntermann, C., Schiller, S., Klosterkötter, J., Hambrecht, M., & Pukrop, R. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00300.x · Cited by 133
Gäebel, W., Jänner, M., Frommann, N., Pietźcker, A., Köpcke, W., Linden, M., Müller, P., Müller-Spahn, F., & Tegeler, J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00182-7 · Cited by 133
Early intervention, untreated psychosis and the course of early schizophrenia
Linszen, D. H., Lenior, M. E., de Haan, L., Dingemans, P. M. A. J., & Gersons, B. P. R. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000297717 · Cited by 127
Rettenbacher, M. A., Hofer, A., Eder, U., Hummer, M., Kemmler, G., Weiss, E. M., & Fleischhacker, W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0908 · Cited by 126
Compliance with treatment in schizophrenia: a drug intervention program in a developing country
Salleh, M. R., & Yahya, H. M. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09790.x · Cited by 124
Chen, E. Y.-H., Hui, C. L.-M., Dunn, E. L.-W., Miao, M. Y.-K., Yeung, W.-S., Wong, C.-K., Chan, W.-F., & Tang, W.-N. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.020 · Cited by 123
Diaz, E., Levine, H. B., Sullivan, M. C., Sernyak, M. J., Hawkins, K. A., Cramer, J. A., & Woods, S. W. (2001) · PubMed Central · Cited by 123
Assessment and Treatment Selection for “Revolving Door” Inpatients with Schizophrenia
Weiden, P. J., & Glazer, W. M. (1997) · Psychiatric Quarterly · doi:10.1023/a:1025499131905 · Cited by 121
A prospective evaluation of adherence to medication in first episode schizophrenia
Kamali, M., Kelly, B. D., Clarke, M., Browne, S., Gervin, M., Kinsella, A., Lane, A., Larkin, C., & O’Callaghan, E. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2005.05.015 · Cited by 119
Medication Compliance and Substance Abuse Among Schizophrenic Patients
Pristach, C. A., & Smith, C. M. (1990) · Psychiatric Services · doi:10.1176/ps.41.12.1345 · Cited by 118
Donohoe, G. J., Owens, N., O’Donnell, C. P., Burke, T., Moore, L., Tobin, A., & O’Callaghan, E. (2001) · European Psychiatry · doi:10.1016/s0924-9338(01)00581-8 · Cited by 118
Yen, C., Chen, C., Ko, C., Yeh, M.-L., Yang, S., Yen, J., Huang, C., & Wu, C. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01392.x · Cited by 117
Housing instability and homelessness among rural schizophrenic patients
Drake, R. E., Wallach, M. A., Teague, G. B., Freeman, D. H., Paskus, T. S., & Clark, T. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.3.330 · Cited by 117
Eaddy, M. T., Grogg, A. L., & Locklear, J. C. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.02.003 · Cited by 113
Family education for people with schizophrenia in Beijing, China: Randomised controlled trial
Li, Z., & Arthur, D. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.4.339 · Cited by 112
Menzin, J., Boulanger, L., Friedman, M., Mackell, J. A., & Lloyd, J. R. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.5.719 · Cited by 111
The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial
Fleischhacker, W. W., Keet, I. P. M., & Kahn, R. S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.004 · Cited by 110
Linking Inpatients With Schizophrenia to Outpatient Care
Olfson, M., Mechanic, D., Boyer, C. A., & Hansell, S. (1998) · Psychiatric Services · doi:10.1176/ps.49.7.911 · Cited by 110
Gray, R. J., Wykes, T., Edmonds, M., Leese, M., & Gournay, K. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.185.2.157 · Cited by 108
Neuroleptic compliance among chronic schizophrenic outpatients: An intervention outcome report.
Boczkowski, J. A., Zeichner, A., & DeSanto, N. (1985) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.53.5.666 · Cited by 108
Predicting Medication Compliance in a Psychotic Population
Adams, S. G., & HOWE, J. T. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199309000-00005 · Cited by 107
Birchwood, M. J., Cochrane, R., Macmillan, F., Copestake, S., Kucharska, J., & Cariss, M. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.6.783 · Cited by 106
Psychopharmacology: Perspectives on Medication Adherence and Atypical Antipsychotic Medications
Velligan, D. I., Lam, F., Ereshefsky, L., & Miller, A. L. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.5.665 · Cited by 105
Self-citationBrown, C., Wright, R. G., & Christensen, D. B. (1987) · Psychiatric Services · doi:10.1176/ps.38.1.55 · Cited by 103
Garavan, J., Browne, S., Gervin, M., Lane, A., Larkin, C., & O’Callaghan, E. (1998) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(98)90063-3 · Cited by 101
Adherence Assessments and the Use of Depot Antipsychotics in Patients With Schizophrenia
Valenstein, M. M., Copeland, L. A., Owen, R. R., Blow, F. C., & Visnic, S. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n07a08 · Cited by 101
Psychiatric patients' attitudes about medication and factors affecting noncompliance
Ruscher, S. M., de Wit, R., & Mazmanian, D. S. (1997) · Psychiatric Services · doi:10.1176/ps.48.1.82 · Cited by 99
Medication Self-Management: A preliminary report on an intervention to improve medication compliance
Hayward, P. (1995) · Journal of Mental Health · doi:10.1080/09638239550037343 · Cited by 99
Kamali, M., Kelly, L., Gervin, M., Browne, S., Larkin, C., & O'Callaghan, E. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101006452.x · Cited by 98
Assertive community treatment and medication compliance in the homeless mentally ill
Dixon, L. B., Weiden, P. J., Torres, M., & Lehman, A. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1302 · Cited by 98
Arango, C., Bombín, I., González-Salvador, T., García‐Cabeza, I., & Bobes, J. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.07.006 · Cited by 96
Dossenbach, M. R. K., Arango-Dávila, C. A., Ibarra, H. S., Landa, E., Aguilar, J., Caro, O., Leadbetter, J., & Assunção, S. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0810 · Cited by 93
Characteristics of Patients with Schizophrenia Who Do Not Believe They Are Mentally Ill
Pyne, J. M., Bean, D. L., & Sullivan, G. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200103000-00002 · Cited by 92
Medication compliance among the seriously mentally ill in a public mental health system
Nageotte, C., Sullivan, G., Duan, N., & Camp, P. (1997) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788920 · Cited by 91
Vaughan, K., McConaghy, N., Wolf, C., Myhr, C., & Black, T. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2000.00813.x · Cited by 91
Expressed Emotion: Relevance to Rehospitalization in Schizophrenia Over 7 Years
Marom, S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi016 · Cited by 88
Sellwood, W., Barrowclough, C., Tarrier, N., Quinn, J., Mainwaring, J., & Lewis, S. W. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00502.x · Cited by 86
Kamali, M., Kelly, L. S., Gervin, M., Browne, S., Larkin, C., & O’Callaghan, E. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.2.161 · Cited by 84
McEvoy, J. P., Howe, A., & Hogarty, G. E. (1984) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198407000-00007 · Cited by 83
Rosenheck, R. A., Chang, S. S., Choe, Y., Cramer, J. A., Xu, W., Thomas, J. M., Henderson, W. G., & Charney, D. S. (2000) · PubMed · Cited by 83
Kinon, B. J., Hill, A. L., Liu, H., & Kollack‐Walker, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003389 · Cited by 82
A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective Disorder
Byerly, M., Fisher, R., Carmody, T. J., & Rush, A. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0806 · Cited by 82
Alcohol, Cannabis, Nicotine, and Caffeine Use and Symptom Distress in Schizophrenia
Hamera, E. K., Schneider, J. K., & DeViney, S. (1995) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199509000-00001 · Cited by 81
Bechdolf, A., Köhn, D., Knost, B., Pukrop, R., & Klosterkötter, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00581.x · Cited by 80
Psychoeducational training for schizophrenic patients: background, procedure and empirical findings
Hornung, W. P., Kieserg, A., Feldmann, R., & Buchkremer, G. (1996) · Patient Education and Counseling · doi:10.1016/s0738-3991(96)00918-4 · Cited by 79
Weiden, P. J., Rapkin, B. D., Zygmunt, A., Mott, T., Goldman, D. A., & Frances, A. (1995) · Psychiatric Services · doi:10.1176/ps.46.10.1049 · Cited by 79
Demographic factors associated with extreme non-compliance in schizophrenia
Sellwood, W., & Tarrier, N. (1994) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00802014 · Cited by 78
Agarwal, M., Sharma, V. K., Kishore Kumar, K. V., & Lowe, D. (1998) · International Journal of Social Psychiatry · doi:10.1177/002076409804400202 · Cited by 76
Brief Evaluation of Medication Influences and Beliefs
Dolder, C. R., Lacro, J. P., Warren, K. A., Golshan, S., Perkins, D. O., & Jeste, D. V. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130554.63254.3a · Cited by 75
First-episode non-affective psychosis in a total urban population: a 5-year follow-up
Svedberg, B., Mesterton, A., & Cullberg, J. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170037 · Cited by 74
Medication Continuation and Compliance
Rosenheck, R. A., Chang, S. S., Choe, Y. H., Cramer, J. A., Xu, W., Thomas, J., Henderson, W. G., & Charney, D. S. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0511 · Cited by 73
Family Characteristics, Substance Abuse, and Hospitalization Patterns of Patients With Schizophrenia
Kashner, T. M., Rader, L. E., Rodell, D. E., Beck, C. M., Rodell, L., & Muller, K. (1991) · Psychiatric Services · doi:10.1176/ps.42.2.195 · Cited by 72
Telemonitoring of Medication Adherence in Patients with Schizophrenia
Frangou, S., Sachpazidis, I., Stassinakis, A., & Sakas, G. (2005) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2005.11.675 · Cited by 68
SUBJECTIVE ILLNESS THEORY AND ANTIPSYCHOTIC MEDICATION COMPLIANCE BY PATIENTS WITH SCHIZOPHRENIA
Holzinger, A., Löffler, W., MÜLLER, P., Priebe, S., & Angermeyer, M. C. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200209000-00004 · Cited by 67
Attitude towards antipsychotics among out‐patients with schizophrenia in Nigeria
Adewuya, A. O., Ola, B. A., Mosaku, K. S., Fatoye, F., & Eegunranti, B. A. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00745.x · Cited by 66
Effect of Patient and Family Insight on Compliance of Schizophrenic Patients
Smith, C. M., Barzman, D. H., & Pristach, C. A. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04773.x · Cited by 63
Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study
Yamada, K., Watanabe, K., Nemoto, N., Fujita, H., Chikaraishi, C., Yamauchi, K., Yagi, G., Asai, M., & Kanba, S. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.07.014 · Cited by 63
Linden, M., Godemann, F., Gäebel, W., Köpke, W., Muller, P., Müller-Spahn, F., Pietzcker, A., & Tegeler, J. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006898 · Cited by 63
Abas, M., Vanderpyl, J., Prou, T. L., Kydd, R. R., Emery, B., & Foliaki, S. A. (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2003.01229.x · Cited by 62
Sellwood, W., Tarrier, N., QUINN, J., & Barrowclough, C. (2002) · Psychological Medicine · doi:10.1017/s0033291702006888 · Cited by 62
Attitudes and Behaviors of Acute and Chronic Schizophrenic Patients Regarding Ambultory Treatment
Serban, G., & Thomas, A. J. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.9.991 · Cited by 60
Gäebel, W., & Pietzcker, A. (1985) · Pharmacopsychiatry · doi:10.1055/s-2007-1017372 · Cited by 58
A Randomized Clinical Trial of Inpatient Family Intervention: VI. Mediating Variables and Outcome
Glick, I. D., Clarkin, J. F., Haas, G. L., SPENCER, J. H., & CHEN, C. L. (1991) · Family Process · doi:10.1111/j.1545-5300.1991.00085.x · Cited by 55
Drug default among schizophrenic patients
Nelson, A. A., Gold, B. H., Hutchinson, R. A., & Benezra, E. (1975) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/32.12.1237 · Cited by 55
Duncan, J., & Rogers, R. (1998) · Journal of Forensic Sciences · doi:10.1520/jfs14375j · Cited by 53
Rosa, M. A., Marcolin, M. A., & Elkis, H. (2005) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462005000300005 · Cited by 53
Elbogen, E. B., Swanson, J. W., Swartz, M. S., & Dorn, R. A. V. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000180742.51075.70 · Cited by 52
A Cognitive-Behavioral Program to Improve Compliance with Medication in Patients with Schizophrenia
Lecompte, D., & Pelc, I. (1996) · International Journal of Mental Health · doi:10.1080/00207411.1996.11449333 · Cited by 51
Glick, I. D., & Berg, P. H. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200203000-00004 · Cited by 51
Grunebaum, M. F., Weiden, P. J., & Olfson, M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0515 · Cited by 50
Parker, G. B., & Hadži-Pavlović, D. (1995) · Psychological Medicine · doi:10.1017/s0033291700028178 · Cited by 48
Lindstr�m, L. H. (1989) · Psychopharmacology · doi:10.1007/bf00442567 · Cited by 48
Nakonezny, P. A., & Byerly, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.015 · Cited by 46
Cost-Effectiveness of Risperidone, Olanzapine, and Conventional Antipsychotic Medications
Jerrell, J. M. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006967 · Cited by 46
García‐Cabeza, I., Gómez, J.-C., Sacristán, J. A., Edgell, E. T., & de Chávez, M. G. (2001) · BMC Psychiatry · doi:10.1186/1471-244x-1-7 · Cited by 43
Klingberg, S., Buchkremer, G., Holle, R., Mönking, H. S., & Hornung, W. P. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050068 · Cited by 40
Age and other factors relevant to the rehospitalization of schizophrenic outpatients
Hoffmann, H. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb08093.x · Cited by 40
Christensen, J. (1974) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1974.tb07657.x · Cited by 39
Understanding adherence to neuroleptic treatment in schizophreniaı
Vauth, R., Löschmann, C., Rüsch, N., et al. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2003.07.004 · Cited by 36
Psychosocial interventions for schizophrenia
Razali, S. M. (2000) · Journal of Mental Health · doi:10.1080/jmh.9.3.283.289 · Cited by 35
Familial Expressed Emotion: Outcome and Course of Israeli Patients With Schizophrenia
Marom, S., Munitz, H., Jones, P. B., Weizman, A., & Hermesh, H. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006976 · Cited by 34
Determinants of Anti-Psychotic Medication Compliance in a Multicultural Population
Ziguras, S. J., Klimidis, S., Lambert, T. J. R., & Jackson, A. C. (2001) · Community Mental Health Journal · doi:10.1023/a:1017585231773 · Cited by 33
Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study
Christensen, A. F., Poulsen, J., Nielsen, C. T., Bork, B., Christensen, A. M. B., & Christensen, M. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00736.x · Cited by 32
Medication compliance in a Chinese psychiatric out‐patient setting
Chan, D. W. (1984) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1984.tb01585.x · Cited by 30
Rijcken, C. A. W., Tobi, H., Vergouwen, A. C. M., & den Berg, L. T. W. D. J. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.951 · Cited by 29
Hertling, I., Philipp, M., Dvorak, A., Gläser, T., Mast, O., Beneke, M., Ramskogler, K., Saletu-Zyhlarz, G. M., Walter, H., & Lesch, O. (2003) · Neuropsychobiology · doi:10.1159/000068874 · Cited by 28
Development of a Structural Model Explaining Medication Compliance of Persons with Schizophrenia
Seo, M.-A., & Min, S.-K. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.3.331 · Cited by 27
The use of group programs to improve medication compliance in patients with chronic diseases
Guimón, J. (1995) · Patient Education and Counseling · doi:10.1016/0738-3991(95)00732-f · Cited by 26
Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics
Kapur, S., Ganguli, R., Ulrich, R. F., & Raghu, U. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90020-r · Cited by 26
Suzuki, T., Uchida, H., Takeuchi, H., Nomura, K., Tanabe, A., Watanabe, K., Yagi, G., & Kashima, H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0018-3 · Cited by 25
Relapse of psychiatric patients in foster care
Linn, M. W., Klett, C. J., & Caffey, E. M. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.6.778 · Cited by 25
EXPRESSED EMOTION AND RELAPSE OF SCHIZOPHRENIA IN HONG KONG
Ng, R., Mui, J. H. C., Cheung, H. K., & Leung, S. (2001) · Hong Kong journal of psychiatry · Cited by 24
Switching From Depot Antipsychotic Drugs to Olanzapine in Patients With Chronic Schizophrenia
Godleski, L., Goldsmith, L. J., Vieweg, W. V. R., Zettwoch, N. C., Stikovac, D., & Lewis, S. J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0203 · Cited by 24
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
Joyce, A. T., Harrison, D. J., Loebel, A. D., & Ollendorf, D. A. (2005) · PubMed · Cited by 21
Giron, M., & Gómez-Beneyto, M. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033353 · Cited by 21
Fernando, M. L. D., Velamoor, V. R., Cooper, A., et al. (1990) · The Canadian Journal of Psychiatry · doi:10.1177/070674379003500111 · Cited by 20
Norman, R. M. G., & MALLA, A. K. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200205000-00010 · Cited by 20
Drug refusal among schizophrenic patients treated in the community
Jerrom, B. (1997) · Journal of Mental Health · doi:10.1080/09638239718905 · Cited by 17
Girón, M., & Gómez-Beneyto, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700036266 · Cited by 15
Distribution of EE and Its Relationship to Relapse in Japan
Ito, J., & Oshima, I. (1995) · International Journal of Mental Health · doi:10.1080/00207411.1995.11449310 · Cited by 12
Program-Level Predictors of Antipsychotic Medication Adherence among Parolees
Farabee, D. J., Shen, H., & Sanchez, S. G. (2004) · International Journal of Offender Therapy and Comparative Criminology · doi:10.1177/0306624x04263884 · Cited by 12
Predictors of Management Problems in Supported Housing: A Pilot Study
Grunebaum, M. F., Aquila, R., Portera, L., Leon, A. C., & Weiden, P. J. (1999) · Community Mental Health Journal · doi:10.1023/a:1018768614068 · Cited by 10
Trauer, T. (1998) · Journal of Mental Health · doi:10.1080/09638239817770 · Cited by 10
Cited by
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Self-report measures of medication adherence behavior: recommendations on optimal use
Stirratt, M. J., Dunbar-Jacob, J., Crane, H. M., Simoni, J. M., Czajkowski, S., Hilliard, M. E., Aikens, J. E., Hunter, C. M., Velligan, D. I., Huntley, K., et al. (2015) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0315-2 · Cited by 824
Self-citationBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Metadata
- Authors
- Velligan, D. I., Lam, Y.-W. F., Glahn, D. C., Barrett, J. A., Maples, N. J., Ereshefsky, L., & Miller, A. L.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-12
- Volume
- 32
- Issue
- 4
- Pages
- 724-742
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2087709083
- Cited by
- 309
- References
- 163
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.